Jiang Zhong Pharmaceutical Co.,Ltd

XSSC:600750 Stock Report

Market Cap: CN¥14.3b

Jiang Zhong PharmaceuticalLtd Past Earnings Performance

Past criteria checks 4/6

Jiang Zhong PharmaceuticalLtd has been growing earnings at an average annual rate of 11.6%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 14.7% per year. Jiang Zhong PharmaceuticalLtd's return on equity is 18.5%, and it has net margins of 17.7%.

Key information

11.6%

Earnings growth rate

11.5%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate14.7%
Return on equity18.5%
Net Margin17.7%
Next Earnings Update20 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Jiang Zhong PharmaceuticalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XSSC:600750 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 244,43578500
30 Sep 244,1257501,620140
30 Jun 244,2017471,693153
31 Mar 244,2737331,730135
31 Dec 234,3907081,837133
30 Sep 234,2486861,85798
30 Jun 234,3466561,967102
31 Mar 234,2996571,91499
31 Dec 223,8855981,715100
30 Sep 223,8115591,713113
30 Jun 223,5095911,49499
31 Mar 223,1275301,33896
31 Dec 212,8745061,19688
30 Sep 212,6445281,07070
30 Jun 212,5495101,02866
31 Mar 212,5945021,03866
31 Dec 202,44147496456
30 Sep 202,48148099751
30 Jun 202,46748297650
31 Mar 202,4374681,01346
31 Dec 192,4494641,03348
30 Sep 192,16749881445
30 Jun 192,00149472841
31 Mar 191,83248162336
31 Dec 181,75547059730
30 Sep 181,73145062926
30 Jun 181,76443665831
31 Mar 181,77842569827
31 Dec 171,74741868123
30 Sep 171,76443865612
30 Jun 171,5553865910
31 Mar 171,4973745610
31 Dec 161,5483726360
30 Sep 161,8054016510
30 Jun 162,1504247310
31 Mar 162,4554118090
31 Dec 152,5973677950
30 Sep 152,6643328390
30 Jun 152,7633089420
31 Mar 152,7572759730
31 Dec 142,8342651,0460
30 Sep 142,9521881,1230
30 Jun 142,8721541,0340
31 Mar 142,8291429450

Quality Earnings: 600750 has high quality earnings.

Growing Profit Margin: 600750's current net profit margins (17.7%) are higher than last year (16.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 600750's earnings have grown by 11.6% per year over the past 5 years.

Accelerating Growth: 600750's earnings growth over the past year (10.8%) is below its 5-year average (11.6% per year).

Earnings vs Industry: 600750 earnings growth over the past year (10.8%) exceeded the Pharmaceuticals industry -2.5%.

Return on Equity

High ROE: 600750's Return on Equity (18.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/29 06:55
End of Day Share Price 2025/01/27 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jiang Zhong Pharmaceutical Co.,Ltd is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jun WangBOCI Research Ltd.
Shuchang LiuChangjiang Securities Co. LTD.
Shanshan LiChina Merchants Securities Co. Ltd.